These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3890481)

  • 1. Nephrotoxicity of antifungal agents.
    Yang DJ; Rankin GO
    Adverse Drug React Acute Poisoning Rev; 1985; 4(1):37-47. PubMed ID: 3890481
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical pharmacology of antifungal agents in deep mycoses].
    Azanza Perea JR; Honorato Pérez J; Cuena Boy R
    Rev Med Univ Navarra; 1983 Sep; 27(3):19-24. PubMed ID: 6669848
    [No Abstract]   [Full Text] [Related]  

  • 3. Nephrotoxicity in the setting of invasive fungal diseases.
    Ullmann AJ
    Mycoses; 2008; 51 Suppl 1():25-30. PubMed ID: 18471158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of fungal infections of the central nervous system.
    Bell WE
    Ann Neurol; 1981 May; 9(5):417-22. PubMed ID: 7023352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Commonly used antifungal agents in the treatment of systemic mycoses].
    Berenguer Berenguer J
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():58-65. PubMed ID: 9441308
    [No Abstract]   [Full Text] [Related]  

  • 6. Topical and systemic antifungal agents.
    Bodey GP
    Med Clin North Am; 1988 May; 72(3):637-59. PubMed ID: 3280911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic antifungal drugs.
    Med Lett Drugs Ther; 1996 Feb; 38(967):10-2. PubMed ID: 8559113
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapy with amphotericin B and other new antifungal agents.
    Riley HD
    J Okla State Med Assoc; 1974 Apr; 67(4):141-5. PubMed ID: 4596788
    [No Abstract]   [Full Text] [Related]  

  • 9. Antifungal agents used for deep-seated mycotic infections.
    Terrell CL; Hermans PE
    Mayo Clin Proc; 1987 Dec; 62(12):1116-28. PubMed ID: 3682956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of the treatment of fungal infections.
    O'Grady F
    J R Coll Physicians Lond; 1972 Oct; 7(1):45-52. PubMed ID: 4561729
    [No Abstract]   [Full Text] [Related]  

  • 11. Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries.
    Ullmann AJ; Sanz MA; Tramarin A; Barnes RA; Wu W; Gerlach BA; Krobot KJ; Gerth WC;
    Clin Infect Dis; 2006 Aug; 43(4):e29-38. PubMed ID: 16838223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antimycotic agents in generalized fungal infections].
    van 't Wout JW; van Furth R
    Ned Tijdschr Geneeskd; 1988 May; 132(20):900-4. PubMed ID: 3374679
    [No Abstract]   [Full Text] [Related]  

  • 13. Should we continue using amphotericin B deoxycholate for the treatment of fungal infections? Adverse events and clinical outcomes.
    Garbino J; Markham L; Matulionyte R; Rives V; Lew D
    Scand J Infect Dis; 2006; 38(2):110-3. PubMed ID: 16449001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms and management of amphotericin B-induced nephrotoxicity.
    Miano-Mason TM
    Cancer Pract; 1997; 5(3):176-81. PubMed ID: 9171554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic safety of antimycotics in the treatment of systemic fungal infections].
    Fehér J; Lengyel G
    Orv Hetil; 2003 Aug; 144(34):1677-82. PubMed ID: 14528841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of systemic fungal infections: alternatives to itraconazole.
    Herbrecht R; Nivoix Y; Fohrer C; Natarajan-Amé S; Letscher-Bru V
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i39-i48. PubMed ID: 16120633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological risk factors for amphotericin B nephrotoxicity in children.
    Goldman RD; Ong M; Wolpin J; Doyle J; Parshuram C; Koren G
    J Clin Pharmacol; 2007 Aug; 47(8):1049-54. PubMed ID: 17525169
    [No Abstract]   [Full Text] [Related]  

  • 18. Is liposomal amphotericin B really safety in neonates?
    Karadag-Oncel E; Ozsurekci Y; Yurdakok M; Kara A
    Early Hum Dev; 2013 Jan; 89(1):35-6. PubMed ID: 22877627
    [No Abstract]   [Full Text] [Related]  

  • 19. Antifungal drugs.
    Hay RJ
    QJM; 1995 Oct; 88(10):681-4. PubMed ID: 7493164
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to "is liposomal amphotericin B really safety in neonates?".
    Manzoni P; Rizzollo S; Farina D
    Early Hum Dev; 2013 Jan; 89(1):37. PubMed ID: 22831635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.